PURE Bioscience (OTCMKTS:PURE – Get Free Report) shares passed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $0.07 and traded as high as $0.0802. PURE Bioscience shares last traded at $0.0769, with a volume of 1,850 shares trading hands.
PURE Bioscience Stock Performance
The company has a market cap of $11.29 million, a P/E ratio of -2.89 and a beta of 0.33. The company has a fifty day moving average price of $0.07 and a two-hundred day moving average price of $0.07.
PURE Bioscience Company Profile
PURE Bioscience, Inc develops and commercializes antimicrobial products based on its proprietary silver dihydrogen citrate (SDC) technology. SDC is designed to provide broad-spectrum antimicrobial activity while serving as the active ingredient in disinfecting, sanitizing, and hygiene formulations.
The company’s product portfolio has included PURE-branded solutions for hard-surface disinfection and sanitation, as well as applications in food safety, commercial and industrial settings, healthcare, and other environments where microbial control is important.
Featured Articles
- Five stocks we like better than PURE Bioscience
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
- Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
- Palantir’s Next Big Test Isn’t a Partnership—It’s the Numbers
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
